Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sabighoh Zanjabila"'
Autor:
Suwarti Suwarti, Gilbert Lazarus, Sabighoh Zanjabila, Robert Sinto, Fransiska Fransiska, Theresia Deborah, Dwi Oktavia, Junaidah Junaidah, Santayana Santayana, Henry Surendra, Jeng Yuliana, Herlina Pardosi, Nunung Nuraeni, Saraswati Soebianto, Novi Dwi Susilowati, Decy Subekti, Ariel Pradipta, J. Kevin Baird, Le Van Tan, Susanna Dunachie, Anuraj H. Shankar, Erni J. Nelwan, Raph L. Hamers, SEACOVARIANTS Consortium
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Data on the dynamics and persistence of humoral immunity against SARS-CoV-2 after primary vaccination with two-dose inactivated vaccine (CoronaVac) are limited. This study evaluated the sequential effects of prior infection, heter
Externí odkaz:
https://doaj.org/article/894d94ef86094d81adca59a2c5c15243
Autor:
Anis Karuniawati, Ayodhia Pitaloka Pasaribu, Gilbert Lazarus, Vera Irawany, Dwi Utomo Nusantara, Robert Sinto, Suwarti, Maulana Jamil Nasution, Ferawati, Muhammad Riza Lubis, Eka Nurfitri, Mutiara Mutiara, Hasanul Arifin, Hely Hely, Pramaisshela Arinda D. Putri, Ariel Pradipta, Anindya Pradipta Susanto, Meutia Ayuputeri Kumaheri, Bonifacius, Yacobus Da Costa, Claus Bogh, Dodi Safari, Kartini Lidia, Hermi Indita Malewa, Nunung Nuraeni, Sabighoh Zanjabila, Mutia Rahardjani, Fitri Agustia Dewi, Fitria Wulandari, Decy Subekti, Henry Surendra, J. Kevin Baird, Anuraj H. Shankar, Raph L. Hamers
Publikováno v:
The Lancet Regional Health - Southeast Asia, Vol 22, Iss , Pp 100348- (2024)
Summary: Background: Limited data exist from southeast Asia on the impact of SARS-CoV-2 variants and inactivated vaccines on disease severity and death among patients hospitalised with COVID-19. Methods: A multicentre hospital-based prospective cohor
Externí odkaz:
https://doaj.org/article/8cddd15f0d2045c4a293489920e319a5
Publikováno v:
Indonesian Journal of Biotechnology, Vol 24, Iss 1, Pp 8-16 (2019)
Recombinant human epidermal growth factor (rh-EGF) has high value in therapies for h-EGF deficiency-related diseases. The expression of the h-EGF gene was designed by using the pET21b(+) vector and Escherichia coli BL21(DE3) as the expression host. I
Externí odkaz:
https://doaj.org/article/f7dc9888606c48559b5ba8e85c60f808
Autor:
Suwarti Suwarti, Sabighoh Zanjabila, null Bonifacius, Yacobus Da Costa, Claus Bogh, Decy Subekti, Jeny Jeny, Ayu Madri Dewi, Nunung Nuraeni, Mutia Rahardjani, Iqbal Elyazar, Erni J. Nelwan, Anuraj H Shankar, J. Kevin Baird, Raph L. Hamers
Publikováno v:
American journal of tropical medicine and hygiene, 107(2), 284-290. American Society of Tropical Medicine and Hygiene
Standard diagnosis of SARS-CoV-2 by nasopharyngeal swab (NPS) and real-time reverse transcriptase-polymerase chain reaction (PCR) requires a sophisticated laboratory, skilled staff, and expensive reagents that are difficult to establish and maintain
Publikováno v:
Indonesian Journal of Pharmacy. :493-502
Recombinant human epidermal growth factor (rhEGF) has been studied and expressed in various expression systems. It has been also commercialized and clinically used, yet limited to topical diseases. However, being naturally expressed in different tiss
Autor:
Riyona Desvy Pratiwi, Asrul Muhamad Fuad, Aminah Aminah, Sabighoh Zanjabila, Swastika Praharyawan, Dian Fairuza
Publikováno v:
ANNALES BOGORIENSES. 24:11
Probiotic has been widely used in functional food because of numerous advantages for health. MRS broth is commonly used as standard medium in studying lactobacilli. However, in some communities - like muslim and vegetarian society, components in MRS
Publikováno v:
Indonesian Journal of Biotechnology; Vol 24, No 1 (2019); 8-16
Recombinant human epidermal growth factor (rh-EGF) has high value in therapies for h-EGF deficiency-related diseases. The expression of the h-EGF gene was designed by using the pET21b(+) vector and Escherichia coli BL21(DE3) as the expression host. I